“STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS”. 2018. International Research Journal of Pharmacy 9 (8): 125-28. https://doi.org/10.56802/gzfvmr94.